FPF
ELOS

FNY Partners Fund’s Syneron Medical Ltd ELOS Stock Holding History

FNY Partners Fund’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-18,200
Closed -$199K – 802
2017
Q2 		$199K Buy
18,200
+16,200
+810% +$178K 0.05% 143
2017
Q1 		$21K Buy
+2,000
New +$19.3K ﹤0.01% 947

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

FNY Partners Fund's ELOS Position: Q3 2017 in Review

FNY Partners Fund sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 18,200 shares — an estimated $199K sold.

FNY Partners Fund first reported a position in ELOS in Q1 2017 and held it in 2 quarters. The position peaked at $199K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • FNY Partners Fund reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • FNY Partners Fund sold 18,200 Syneron Medical Ltd shares in Q3 2017, an estimated $199K.
  • FNY Partners Fund first reported a position in Syneron Medical Ltd in Q1 2017 and held it in 2 quarters.
  • FNY Partners Fund's Syneron Medical Ltd position peaked at $199K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.